stimulant
What are stimulants and how do they affect the body?
What are some historical uses of stimulants?
What are the major classes of stimulant drugs?
What is the misuse potential of stimulants?
stimulant, substance that increases activity in the central nervous system, enhancing alertness, attention, wakefulness, energy, and, in some cases, mood and physical performance. Prescription stimulants were first used in the 1930s to treat narcolepsy. However, the therapeutic use of stimulants is limited by their mood-elevating effects, which make some of them potent drugs of misuse.
Historical use
Humans have used naturally occurring stimulants for centuries. Cocaine, an alkaloid derived from the leaves of the South American coca plant (Erythroxylum coca), has been consumed by Indigenous peoples in the Andes for thousands of years. Likewise, caffeine-containing beverages such as tea, coffee, and cacao have long played important roles in human cultures worldwide.
The modern era of stimulant pharmacology began with the synthesis of amphetamine in the late 19th century and its medical development in the 1920s and 1930s. By the mid-20th century, prescription stimulants had become established treatments for disorders such as narcolepsy and, later, attention-deficit/hyperactivity disorder (ADHD), while growing recognition of their misuse led to increasing regulation.
" height="20" alt="HEW Logo">
Mechanisms of action
In general, most stimulants exert their effects by increasing the activity of one or more neurotransmitters—primarily dopamine and norepinephrine, and, to a lesser extent, serotonin—within the brain. Dopamine is involved in motivation, reward, movement, and reinforcement of behavior, whereas norepinephrine promotes alertness and attention and triggers the sympathetic nervous system’s fight-or-flight response. Serotonin influences mood, emotional regulation, and sleep.
Types
The principal stimulant drugs can be divided into several major classes, each characterized by distinct chemical properties, mechanisms of action, and clinical uses.
- Amphetamines: Synthetic compounds that increase the release of dopamine and norepinephrine while inhibiting their reuptake. They are prescribed primarily to treat ADHD and narcolepsy, although methamphetamine has limited medical use because of its high misuse potential.
- Methylphenidates: Synthetic piperidine derivatives that primarily block the reuptake of dopamine and norepinephrine. They are widely used to treat ADHD and narcolepsy.
- Methylxanthines: Naturally occurring purine alkaloids found in coffee, tea, cacao, and other plants. They promote wakefulness chiefly by blocking adenosine receptors. Caffeine is consumed worldwide in foods and beverages, whereas theophylline is used less commonly as a bronchodilator in asthma and chronic obstructive pulmonary disease (COPD).
- Cocaine: Naturally occurring tropane alkaloid obtained from the leaves of the coca plant (E. coca). It blocks the reuptake of dopamine, norepinephrine, and serotonin and has limited medical use as a topical local anesthetic and vasoconstrictor, particularly in certain ear, nose, and throat procedures.
- Nicotine: Naturally occurring alkaloid found primarily in tobacco plants. It stimulates nicotinic acetylcholine receptors, increasing the release of dopamine and other neurotransmitters. Although best known as the addictive component of tobacco products, nicotine is also used therapeutically in nicotine replacement products to aid smoking cessation.
In addition to these major classes, several newer medications, including the wakefulness-promoting agents modafinil and armodafinil, are used clinically to treat excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift-work sleep disorder. Although these drugs share some pharmacological features with classic stimulants, they differ in chemical structure, mechanism of action, and misuse potential.
Misuse potential and regulation
Because stimulants increase dopamine signaling within the brain’s reward pathways, many have the potential to be misused and to cause dependence. The degree of misuse potential varies considerably among different stimulant classes. Cocaine and methamphetamine are among the most addictive because they produce rapid, large increases in brain dopamine, resulting in intense feelings of euphoria. Prescription stimulants, including amphetamine and methylphenidate, can also be misused, particularly when taken in larger doses than prescribed or by individuals without a medical indication. Misuse may involve attempts to enhance academic or athletic performance, increase wakefulness, or induce euphoria.
The trusted destination for professionals, college students, and lifelong learners.
SUBSCRIBE
Repeated stimulant use can lead to tolerance, in which progressively larger doses are needed to achieve the same effect, as well as psychological dependence and, in some cases, stimulant use disorder. Withdrawal following prolonged use of stimulants typically produces fatigue, increased sleep, depressed mood, difficulty concentrating, and intense drug cravings rather than the severe physical withdrawal symptoms associated with alcohol or opioid dependence. Long-term misuse may also increase the risk of anxiety, psychosis, cardiovascular disease, and other adverse health effects.
To reduce these risks while preserving access for legitimate medical treatment, many stimulants are regulated under national and international drug-control laws. In the United States, amphetamine, methamphetamine, methylphenidate, and cocaine are classified as Schedule II controlled substances under the Controlled Substances Act. This means that they have accepted medical uses but also a high potential for misuse and dependence. Nicotine-containing products are regulated primarily through tobacco-control laws rather than controlled substance legislation, whereas caffeine remains largely unregulated because of its comparatively low misuse potential and widespread use in foods and beverages. Internationally, stimulant manufacture and distribution are governed in part by the 1971 United Nations Convention on Psychotropic Substances, which seeks to balance medical availability with measures to prevent diversion and illicit trafficking.